{"id":"https://openalex.org/W2059537835","doi":"https://doi.org/10.1016/s0378-5173(02)00192-8","title":"Influence of chemical structure of amphiphilic \u03b2-cyclodextrins on their ability to form stable nanoparticles","display_name":"Influence of chemical structure of amphiphilic \u03b2-cyclodextrins on their ability to form stable nanoparticles","publication_year":2002,"publication_date":"2002-08-01","ids":{"openalex":"https://openalex.org/W2059537835","doi":"https://doi.org/10.1016/s0378-5173(02)00192-8","mag":"2059537835","pmid":"https://pubmed.ncbi.nlm.nih.gov/12176268"},"language":"en","primary_location":{"id":"doi:10.1016/s0378-5173(02)00192-8","doi":"https://doi.org/10.1016/s0378-5173(02)00192-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0378-5173(02)00192-8","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067654132","display_name":"Annabelle G\u00e8ze","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I177483745","display_name":"Universit\u00e9 Joseph Fourier","ror":"https://ror.org/02aj0kh94","country_code":"FR","type":"education","lineage":["https://openalex.org/I177483745","https://openalex.org/I899635006"]},{"id":"https://openalex.org/I4387154850","display_name":"D\u00e9partement de Pharmacochimie Mol\u00e9culaire","ror":"https://ror.org/04fhvpc68","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I4387154850","https://openalex.org/I899635006"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Annabelle G\u00e8ze","raw_affiliation_strings":["D\u00e9partement de Pharmacochimie Mol\u00e9culaire, UMR CNRS 5063, UFR Pharmacie, Universit\u00e9 Joseph Fourier-Grenoble I, 5 av. de Verdun, F 38243 Cedex, Meylan, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement de Pharmacochimie Mol\u00e9culaire, UMR CNRS 5063, UFR Pharmacie, Universit\u00e9 Joseph Fourier-Grenoble I, 5 av. de Verdun, F 38243 Cedex, Meylan, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I177483745","https://openalex.org/I4387154850"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071045838","display_name":"So\u00e2d Aous","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I177483745","display_name":"Universit\u00e9 Joseph Fourier","ror":"https://ror.org/02aj0kh94","country_code":"FR","type":"education","lineage":["https://openalex.org/I177483745","https://openalex.org/I899635006"]},{"id":"https://openalex.org/I4387154850","display_name":"D\u00e9partement de Pharmacochimie Mol\u00e9culaire","ror":"https://ror.org/04fhvpc68","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I4387154850","https://openalex.org/I899635006"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Soad Aous","raw_affiliation_strings":["D\u00e9partement de Pharmacochimie Mol\u00e9culaire, UMR CNRS 5063, UFR Pharmacie, Universit\u00e9 Joseph Fourier-Grenoble I, 5 av. de Verdun, F 38243 Meylan Cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement de Pharmacochimie Mol\u00e9culaire, UMR CNRS 5063, UFR Pharmacie, Universit\u00e9 Joseph Fourier-Grenoble I, 5 av. de Verdun, F 38243 Meylan Cedex, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I177483745","https://openalex.org/I4387154850"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036249717","display_name":"Isabelle Baussanne","orcid":"https://orcid.org/0000-0001-9144-6021","observed_orcids":["https://orcid.org/0000-0001-9144-6021"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I177483745","display_name":"Universit\u00e9 Joseph Fourier","ror":"https://ror.org/02aj0kh94","country_code":"FR","type":"education","lineage":["https://openalex.org/I177483745","https://openalex.org/I899635006"]},{"id":"https://openalex.org/I4387154850","display_name":"D\u00e9partement de Pharmacochimie Mol\u00e9culaire","ror":"https://ror.org/04fhvpc68","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I4387154850","https://openalex.org/I899635006"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Isabelle Baussanne","raw_affiliation_strings":["D\u00e9partement de Pharmacochimie Mol\u00e9culaire, UMR CNRS 5063, UFR Pharmacie, Universit\u00e9 Joseph Fourier-Grenoble I, 5 av. de Verdun, F 38243 Meylan Cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement de Pharmacochimie Mol\u00e9culaire, UMR CNRS 5063, UFR Pharmacie, Universit\u00e9 Joseph Fourier-Grenoble I, 5 av. de Verdun, F 38243 Meylan Cedex, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I177483745","https://openalex.org/I4387154850"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050702328","display_name":"Jean\u2010Luc Putaux","orcid":"https://orcid.org/0000-0002-9760-5369","observed_orcids":["https://orcid.org/0000-0002-9760-5369"]},"institutions":[{"id":"https://openalex.org/I177483745","display_name":"Universit\u00e9 Joseph Fourier","ror":"https://ror.org/02aj0kh94","country_code":"FR","type":"education","lineage":["https://openalex.org/I177483745","https://openalex.org/I899635006"]},{"id":"https://openalex.org/I4210086338","display_name":"Centre de Recherches sur les Macromol\u00e9cules V\u00e9g\u00e9tales","ror":"https://ror.org/0003ege03","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I4210086338","https://openalex.org/I4210128300","https://openalex.org/I899635006"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"JeanLuc Putaux","raw_affiliation_strings":["CERMAV UPR 5301, Universit\u00e9 Joseph Fourier, 38400 St. Martin d'H\u00e8res, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CERMAV UPR 5301, Universit\u00e9 Joseph Fourier, 38400 St. Martin d'H\u00e8res, France","institution_ids":["https://openalex.org/I177483745","https://openalex.org/I4210086338"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103531079","display_name":"Jacques Defaye","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I177483745","display_name":"Universit\u00e9 Joseph Fourier","ror":"https://ror.org/02aj0kh94","country_code":"FR","type":"education","lineage":["https://openalex.org/I177483745","https://openalex.org/I899635006"]},{"id":"https://openalex.org/I4387154850","display_name":"D\u00e9partement de Pharmacochimie Mol\u00e9culaire","ror":"https://ror.org/04fhvpc68","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I4387154850","https://openalex.org/I899635006"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jacques Defaye","raw_affiliation_strings":["D\u00e9partement de Pharmacochimie Mol\u00e9culaire, UMR CNRS 5063, UFR Pharmacie, Universit\u00e9 Joseph Fourier-Grenoble I, 5 av. de Verdun, F 38243 Meylan Cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement de Pharmacochimie Mol\u00e9culaire, UMR CNRS 5063, UFR Pharmacie, Universit\u00e9 Joseph Fourier-Grenoble I, 5 av. de Verdun, F 38243 Meylan Cedex, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I177483745","https://openalex.org/I4387154850"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010780802","display_name":"Denis Wouessidjewe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I177483745","display_name":"Universit\u00e9 Joseph Fourier","ror":"https://ror.org/02aj0kh94","country_code":"FR","type":"education","lineage":["https://openalex.org/I177483745","https://openalex.org/I899635006"]},{"id":"https://openalex.org/I4387154850","display_name":"D\u00e9partement de Pharmacochimie Mol\u00e9culaire","ror":"https://ror.org/04fhvpc68","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I4387154850","https://openalex.org/I899635006"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Denis Wouessidjewe","raw_affiliation_strings":["D\u00e9partement de Pharmacochimie Mol\u00e9culaire, UMR CNRS 5063, UFR Pharmacie, Universit\u00e9 Joseph Fourier-Grenoble I, 5 av. de Verdun, F 38243 Meylan Cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement de Pharmacochimie Mol\u00e9culaire, UMR CNRS 5063, UFR Pharmacie, Universit\u00e9 Joseph Fourier-Grenoble I, 5 av. de Verdun, F 38243 Meylan Cedex, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I177483745","https://openalex.org/I4387154850"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5010780802"],"corresponding_institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I177483745","https://openalex.org/I4387154850"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":1.8433,"has_fulltext":false,"cited_by_count":51,"citation_normalized_percentile":{"value":0.80340615,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"242","issue":"1-2","first_page":"301","last_page":"305"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.8256999850273132,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.8256999850273132,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10721","display_name":"Surfactants and Colloidal Systems","score":0.09969999641180038,"subfield":{"id":"https://openalex.org/subfields/1606","display_name":"Physical and Theoretical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10578","display_name":"Supramolecular Chemistry and Complexes","score":0.040699999779462814,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/beta-cyclodextrin","display_name":"\u03b2-cyclodextrin","score":0.8289999961853027},{"id":"https://openalex.org/keywords/amphiphilic-cyclodextrins","display_name":"amphiphilic cyclodextrins","score":0.9419999718666077},{"id":"https://openalex.org/keywords/structure-property-relationships","display_name":"structure-property relationships","score":0.625},{"id":"https://openalex.org/keywords/nanospheres","display_name":"nanospheres","score":0.7350000143051147},{"id":"https://openalex.org/keywords/self-assembly","display_name":"self-assembly","score":0.8640000224113464},{"id":"https://openalex.org/keywords/acylation","display_name":"acylation","score":0.6320000290870667},{"id":"https://openalex.org/keywords/degree-of-substitution","display_name":"degree of substitution","score":0.8519999980926514},{"id":"https://openalex.org/keywords/nonionic-surfactants","display_name":"nonionic surfactants","score":0.8019999861717224},{"id":"https://openalex.org/keywords/nanoparticle-stability","display_name":"nanoparticle stability","score":0.6970000267028809},{"id":"https://openalex.org/keywords/secondary-hydroxyl-groups","display_name":"secondary hydroxyl groups","score":0.6240000128746033}],"concepts":[{"id":"https://openalex.org/C67407626","wikidata":"https://www.wikidata.org/wiki/Q5723218","display_name":"Amphiphile","level":4,"score":0.8779226541519165},{"id":"https://openalex.org/C193557335","wikidata":"https://www.wikidata.org/wiki/Q61424","display_name":"Acylation","level":3,"score":0.7157774567604065},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7068349123001099},{"id":"https://openalex.org/C58226133","wikidata":"https://www.wikidata.org/wiki/Q1324199","display_name":"Pulmonary surfactant","level":2,"score":0.6436150074005127},{"id":"https://openalex.org/C2780263894","wikidata":"https://www.wikidata.org/wiki/Q335268","display_name":"Alkyl","level":2,"score":0.5555487275123596},{"id":"https://openalex.org/C184651966","wikidata":"https://www.wikidata.org/wiki/Q906356","display_name":"Aqueous solution","level":2,"score":0.5178516507148743},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.48657500743865967},{"id":"https://openalex.org/C175528265","wikidata":"https://www.wikidata.org/wiki/Q500256","display_name":"Chemical structure","level":2,"score":0.4615720510482788},{"id":"https://openalex.org/C149556010","wikidata":"https://www.wikidata.org/wiki/Q4782870","display_name":"Aqueous two-phase system","level":3,"score":0.4509468078613281},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.425519198179245},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.3331764340400696},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.21930602192878723},{"id":"https://openalex.org/C15920480","wikidata":"https://www.wikidata.org/wiki/Q421281","display_name":"Copolymer","level":3,"score":0.21682676672935486},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.20284783840179443},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.09342363476753235},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D003505","descriptor_name":"Cyclodextrins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D004339","descriptor_name":"Drug Compounding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008854","descriptor_name":"Microscopy, Electron","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008863","descriptor_name":"Microspheres","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009682","descriptor_name":"Magnetic Resonance Spectroscopy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010316","descriptor_name":"Particle Size","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019032","descriptor_name":"Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047392","descriptor_name":"beta-Cyclodextrins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1016/s0378-5173(02)00192-8","doi":"https://doi.org/10.1016/s0378-5173(02)00192-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0378-5173(02)00192-8","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:12176268","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12176268","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of pharmaceutics","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-00307310v1","doi":null,"is_oa":false,"landing_page_url":"https://hal.science/hal-00307310","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Pharmaceutics, 2002, pp.301-305","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":4,"referenced_works":["https://openalex.org/W1991343251","https://openalex.org/W2029239496","https://openalex.org/W2041324970","https://openalex.org/W2082582589"],"related_works":["https://openalex.org/W2086345784","https://openalex.org/W1137848565","https://openalex.org/W2019858235","https://openalex.org/W2613341759","https://openalex.org/W2018774975","https://openalex.org/W2135023772","https://openalex.org/W1980429945","https://openalex.org/W1991343251","https://openalex.org/W2066601668","https://openalex.org/W2551216582"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}